Prosecution Insights
Last updated: October 04, 2026

Evasc Neurovascular Enterprised Ulc

Technology area: Medical Devices & Mechanical Engineering

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Evasc Neurovascular Enterprised Ulc has 1 pending office action in the Medical Devices & Mechanical Engineering technology area. This action is under review by 1 distinct examiner and 1 distinct art unit. The presence of only 1 pending office action indicates a narrow focus for the company's current patent prosecution activities. This single action is the only active matter currently reported for the entity in this field.

The busiest examiner for this portfolio is ALEMAN, SARAH WEBB, who is handling the 1 pending office action. Since there is only 1 distinct examiner and 1 distinct art unit involved, the prosecution strategy is entirely dependent on the interaction with ALEMAN, SARAH WEBB. The company can focus its resources on the specific technical standards of the Medical Devices & Mechanical Engineering field as interpreted by this single official. The 1 distinct art unit provides a specific context for the 1 pending office action. Understanding the examination patterns of ALEMAN, SARAH WEBB is essential for the successful resolution of the pending matter.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Multi-statute (no §101)1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
1
Mechanical / Eng
100% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
ALEMAN, SARAH WEBB 1 62.1% +23.7%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
17802825 ENDOVASCULAR PROSTHESIS DELIVERY SYSTEM ALEMAN, SARAH WEBB 19d overdue

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
17802825 ENDOVASCULAR PROSTHESIS DELIVERY SYSTEM ALEMAN, SARAH WEBB 19d overdue

Top Art Units

Art UnitApps
3774 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
17802825 ENDOVASCULAR PROSTHESIS DELIVERY SYSTEM ALEMAN, SARAH WEBB 3774 §102§112 Non-Final OA 19d overdue Pending Aug 26, 2022

Managing Evasc Neurovascular Enterprised Ulc's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month